EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 241 filers reported holding EDITAS MEDICINE INC in Q3 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $943,000 | +205.2% | 7,882 | -28.3% | 0.08% | +200.0% |
| Q3 2020 | $309,000 | -8.3% | 11,000 | -3.5% | 0.03% | -18.8% |
| Q2 2020 | $337,000 | +44.0% | 11,400 | -3.3% | 0.03% | -3.0% |
| Q1 2020 | $234,000 | -36.2% | 11,790 | -5.0% | 0.03% | -15.4% |
| Q4 2019 | $367,000 | +26.1% | 12,405 | -3.0% | 0.04% | +18.2% |
| Q3 2019 | $291,000 | -12.9% | 12,790 | -5.2% | 0.03% | -15.4% |
| Q2 2019 | $334,000 | +1.2% | 13,486 | -0.1% | 0.04% | -4.9% |
| Q1 2019 | $330,000 | +9.6% | 13,500 | +1.9% | 0.04% | 0.0% |
| Q4 2018 | $301,000 | -25.3% | 13,250 | +4.5% | 0.04% | -8.9% |
| Q3 2018 | $403,000 | -10.4% | 12,679 | +4.1% | 0.04% | -18.2% |
| Q2 2018 | $450,000 | +41.1% | 12,175 | +13.8% | 0.06% | +25.0% |
| Q4 2017 | $319,000 | – | 10,700 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. VI, L.L.C. | 4,656,173 | $160,824,000 | 96.46% |
| Alphabet Inc. | 256,410 | $8,856,000 | 3.65% |
| Casdin Capital, LLC | 85,470 | $2,952,000 | 3.39% |
| Wildcat Capital Management, LLC | 247,768 | $8,558,000 | 2.98% |
| Omega Fund Management, LLC | 105,007 | $3,627,000 | 2.52% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,709,400 | $59,043,000 | 2.51% |
| EcoR1 Capital, LLC | 87,921 | $3,037,000 | 1.06% |
| Foresite Capital Management III, LLC | 14,500 | $501,000 | 0.39% |
| VIKING GLOBAL INVESTORS LP | 2,135,523 | $73,761,000 | 0.32% |
| Schonfeld Strategic Advisors LLC | 9,726 | $336,000 | 0.14% |